Aethlon Medical, Inc. (NASDAQ:AEMD) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.07 and traded as low as $1.60. Aethlon Medical shares last traded at $1.66, with a volume of 122,480 shares traded.
The company has a 50-day simple moving average of $1.93 and a two-hundred day simple moving average of $2.07. The stock has a market capitalization of $20.14 million, a price-to-earnings ratio of -0.87 and a beta of 0.66.
Aethlon Medical (NASDAQ:AEMD) last issued its earnings results on Tuesday, February 9th. The medical equipment provider reported ($0.20) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.15) by ($0.05). The business had revenue of $0.63 million during the quarter. On average, analysts anticipate that Aethlon Medical, Inc. will post -0.55 EPS for the current fiscal year.
About Aethlon Medical (NASDAQ:AEMD)
Aethlon Medical, Inc, a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system.
Featured Article: Find a Trading Strategy That Works
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.